<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://mdivdconsultant.com/2026/04/10/dati-clinici-e-post-market-canada/</loc><news:news><news:publication><news:name>MD &amp; IVD CONSULTANT</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-04-10T14:00:00+00:00</news:publication_date><news:title>Dati clinici e post-market: come cambia l’approccio regolatorio in Canada</news:title><news:keywords>md, MDSAP, HC, Canada, Dati clinici, Dispositivi equivalenti</news:keywords></news:news><image:image><image:loc>https://mdivdconsultant.com/wp-content/uploads/2026/04/canada-clinica.png?w=150</image:loc></image:image></url></urlset>
